Oyapoc, Richard P.
HRN: 27-93-53 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2025
CEFTRIAXONE 1G (VIAL)
10/12/2025
10/18/2025
IV
2g
OD
Open Dislocation
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes